Parabilis Medicines, Inc. Proceeds from Issuance of Private Placement
Parabilis Medicines, Inc. (PBLS) reported Proceeds from Issuance of Private Placement of $83.33 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfPrivatePlacement · last filed 2026-08-13
- 2026-06-30: Proceeds from Issuance of Private Placement 1 month $787.90M; Proceeds from Issuance of Private Placement 6 month $83.33M.
- 2025-06-30: Proceeds from Issuance of Private Placement 6 month $0.00.
| Period end | Proceeds from Issuance of Private Placement 1 month | Proceeds from Issuance of Private Placement 6 month |
|---|---|---|
| 2026-06-30 | $787.90M 10-Q · filed 2026-08-13 | $83.33M 10-Q · filed 2026-08-13 |
| 2025-06-30 | $0.00 10-Q · filed 2026-08-13 |